It was observed that newer agents with novel mechanisms of action and improved security profiles, like the melatonin agonists, maintain guarantee for that administration of Long-term sleeplessness in aged people. Chronic use of sedative-hypnotic medicines to the management of insomnia does not have an evidence foundation and has become discouraged